Nihon Kohden (OTCMKTS:NHNKY) Sees Unusually-High Trading Volume – Time to Buy?

Shares of Nihon Kohden Corporation (OTCMKTS:NHNKY) saw unusually-strong trading volume on Monday . Approximately 190,420 shares were traded during trading, an increase of 585% from the previous session’s volume of 27,797 shares.The stock last traded at $9.68 and had previously closed at $9.5750.

Analyst Ratings Changes

Separately, Zacks Research upgraded shares of Nihon Kohden to a “hold” rating in a research report on Monday, April 27th. One research analyst has rated the stock with a Strong Buy rating and one has assigned a Hold rating to the stock. According to MarketBeat, the company presently has a consensus rating of “Buy”.

Nihon Kohden Stock Performance

The stock has a market cap of $1.60 billion, a P/E ratio of 16.17 and a beta of 0.39. The stock’s fifty day moving average is $9.01 and its 200 day moving average is $9.90.

Nihon Kohden (OTCMKTS:NHNKY) last posted its quarterly earnings results on Thursday, May 14th. The company reported $0.34 EPS for the quarter, beating the consensus estimate of $0.24 by $0.10. The business had revenue of $453.10 million during the quarter, compared to analyst estimates of $414.40 million. Nihon Kohden had a net margin of 6.08% and a return on equity of 9.46%. Equities research analysts predict that Nihon Kohden Corporation will post 0.6 EPS for the current year.

About Nihon Kohden

Nihon Kohden Corporation is a Tokyo-based manufacturer of medical electronic equipment, founded in 1951. The company has built a reputation for innovation in patient monitoring and diagnostic systems, developing one of Japan’s earliest electrocardiogram (ECG) machines and pioneering transistor-based oscilloscopes for clinical use. Over the decades, Nihon Kohden has expanded its product portfolio to address a wide range of healthcare needs, from emergency response to intensive care and neurology.

The company’s core offerings include patient monitors, ECG and electroencephalograph (EEG) devices, defibrillators, infusion pumps, and neuromonitoring systems.